000 -LEADER |
fixed length control field |
05910nam a22004695i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140310150647.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110601s2011 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781607616443 |
|
978-1-60761-644-3 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC109-216 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.9 |
Edition number |
23 |
264 #1 - |
-- |
Totowa, NJ : |
-- |
Humana Press : |
-- |
Imprint: Humana Press, |
-- |
2011. |
912 ## - |
-- |
ZDB-2-SME |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Safdar, Amar. |
Relator term |
editor. |
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Principles and Practice of Cancer Infectious Diseases |
Medium |
[electronic resource] / |
Statement of responsibility, etc |
edited by Amar Safdar. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XX, 596 p. |
Other physical details |
online resource. |
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Current Clinical Oncology |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Infections in Patients with Cancer – An Overview -- Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation -- Infections in Patients with Hematologic Malignancy -- Infections in Patients with Solid-Organ Cancer -- Infections in Patients Treated with Monoclonal Antineoplastic Therapy -- Infections in Cancer Patients Undergoing Surgical Procedure -- Infections in Critically Ill Cancer Patients -- Management of Neutropenic Patients with Fever -- Controversies in Empiric Therapy for Febrile Neutropenia -- Catheter-Related Bloodstream Infections -- Treatment Strategies for Infected Indwelling Intravascular Devices -- Pneumonia and Other Lung Infections -- Noninfectious Lung Infiltrates Difficult to Distinguish from Pneumonia -- Orointestinal Mucosal Barrier Injury and Risk of Infection -- Intestinal Tract Bacterial Colonization and Host’s Innate Immunity -- Neutropenic Enterocolitis and Clostridium difficile Associated Diarrhea -- Management of Hepatitis B and C Virus Reactivation in Cancer Patients -- Infections in Patients with Genitourinary Tract Cancer -- Central Nervous System Infections in Patients with Cancer -- Endocarditis in Cancer Patients – Endovascular Infections and Noninfectious Paraneoplastic Diseases -- Skin Infections and Disorders Confused with Infections in Cancer Patients -- Overview of Fungal Infections -- Diagnosis of Invasive Fungal Disease in Cancer Patients -- Invasive Candidiasis and Candidemia in Cancer Patients -- Management of Aspergillosis, Zygomycosis, and Other Clinically Relevant Mold Infections in Patient with Cancer -- Endemic Mycosis and Cryptococcal Disease -- Controversies in Management of Invasive Fungal Disease in Cancer Patients -- Fungal Drug Resistance and Pharmacologic Consideration of Dosing New Antifungal Agents -- Immunotherapy for Difficult-to-Treat Invasive Fungal Disease in Patients with Hematologic Malignancy and Stem Cell Transplantation -- Cytomegalovirus in Patients with Cancer -- Epstein-Barr virus, Varicella Zoster virus, and Human Herpes virus 6 & 8 Infections in Cancer Patients -- Respiratory Viruses -- BK, JC and Parvovirus Infections in Patients with Hematologic Malignancy -- Antiviral Drug Resistance and Implications for Prophylaxis for High Risk Cancer Population -- Management of Gram-Positive Bacterial Disease: Stapylococcus aureus, Pneumococcus, Streptococcal and Enterococcal Infections -- Management of Gram-Negative Bacterial Disease in Cancer Patients -- Listeriosis and Nocardiosis in Cancer Population -- Antimicrobial Distribution and Drug-Drug Interaction in Cancer Patients -- Mycobacterium tuberculosis Infection in Cancer Patients -- Nontuberculous Mycobacterial Infections in Cancer Patients -- Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis and Other Parasites -- Zoonoses in Cancer Patients -- Antibiotic Stewardship Considerations for Cancer Centers Coralia Mihu -- Controversies in Planning and Implementation of Antimicrobial Stewardship Programs -- Prevention of Drug Resistance among Common Healthcare- Associated Pathogens – Current Practice and Future Strategies -- Antibacterial, Antifungal and Antiviral Prophylaxis in High-Risk Cancer and Stem Cell Transplant Population -- Controversies in Antimicrobial Prophylaxis -- Protected Environment and Infection Control -- Travel Medicine – Prevention of Tropical and Parasitic Diseases -- Immunization – Strategies to Improve Vaccine Response in Cancer and Hematopoietic Transplant Population. |
520 ## - SUMMARY, ETC. |
Summary, etc |
Principles and Practice of Cancer Infectious Diseases is a comprehensive and insightful work dedicated to elucidating the problem of infections in cancer patients. This essential volume reviews common and less often encountered infections, while establishing the difficulties behind preventing, diagnosing, and treating infectious diseases in cancer patients. Key sections are devoted to the presentation of clinical symptoms and the identification of major etiologic agents. A cadre of leading clinicians provide a detailed assessment of the risk factors for various infections, critical strategies in preventing and managing infections, and study of the interactions between the pathogen and host's immune function and inflammatory response. With its in-depth knowledge and concise treatment of the distinct facets of infections in cancer patients, this volume is an indispensible tool for all infectious disease specialists and clinical oncologists. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine. |
|
Topical term or geographic name as entry element |
Internal medicine. |
|
Topical term or geographic name as entry element |
Hematology. |
|
Topical term or geographic name as entry element |
Emerging infectious diseases. |
|
Topical term or geographic name as entry element |
Oncology. |
|
Topical term or geographic name as entry element |
Medicine & Public Health. |
|
Topical term or geographic name as entry element |
Infectious Diseases. |
|
Topical term or geographic name as entry element |
Oncology. |
|
Topical term or geographic name as entry element |
Hematology. |
|
Topical term or geographic name as entry element |
Internal Medicine. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Printed edition: |
International Standard Book Number |
9781607616436 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-60761-644-3 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
E-Book |